ArticleTherapeutic advances in medical oncology2018

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).

Sara Hurvitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.